The global infectious disease treatment market is presently worth USD 113.5 billion and is poised to amplify at a CAGR of 7.96% over 2022-2030, thereby amassing USD 166.46 billion by end of the assessment timeframe.
One of the major causes of severe burden on the global healthcare industry is infectious disease. These illnesses, which are also known as communicable diseases or transmissible illnesses, are brought on by a variety of infectious agents, including bacteria, viruses, nematodes, ticks, mites, fleas, and lice, fungi like ringworm, and other macroparasites like tapeworms and other helminths. Nematodes include parasitic roundworms and pinworms. The number of deaths brought on by infectious diseases has dropped as a result of the introduction of numerous technologically sophisticated detection and treatment options as well as advancements in cleanliness, immunisation, and antimicrobial therapy.
Market scenario for treatments for infectious diseases:
Numerous species, including bacteria, viruses, fungus, and parasites, can result in infectious disorders. Contagious illnesses that can spread from person to person include several infectious diseases. A small number of these infectious diseases are spread through the bites of insects or other animals, and a smaller number are also contracted through the use of tainted food or water. Acquired immunodeficiency syndrome (AIDS), hepatitis B, tuberculosis (TB), and others are some typical examples of infectious diseases.
One of the key factors propelling the growth of the market for infectious illness treatments during the forecast period is the rising prevalence of infectious diseases like TB, AIDS, and others around the world. One-third of the world's population was afflicted by TB in 2016, according to the Centers for Disease Control and Prevention. In addition, it was projected that 10.4 million individuals worldwide had TB disease, and the illness claimed the lives of 1.7 million people worldwide. Additionally, 36.7 million individuals worldwide had HIV/AIDS in 2016, and the illness claimed 1.0 million lives, according to the World Health Organization.
In addition, rising healthcare costs and rising patient awareness will support the market expansion for infectious illness therapies. The expansion of the infectious illness treatments market, however, may be constrained over the forecast period due to limited treatment uptake and low per capita healthcare spending in developing nations.
Global Infectious Disease Treatment Market- Key trends Increasing geriatric and infant population base is aiding industry expansion
The world is witnessing a rapid surge in the elderly and infant population rate. It is evident that babies and aging people have a weaker immune system and hence are prone to various ailments. Disease causing parasites can easily attack infants and elderly individuals, thereby making them highly susceptible to a wide array of infectious diseases. This in turn is adding traction to the development of this business sphere.
Get Free Sample Report: https://wemarketresearch.com/sample-request/infectious-disease-treatment-market/349/
Global Infectious Disease Treatment Market- Segmental assessment By Mode of Treatment • Drugs • Vaccines The drugs segment is poised to amass notable gains over the stipulated timeline owing to the booming biopharmaceutical sector across the globe. By Target Organism • Antibacterial • Antifungal • Antiviral • Antiparasite • Others The antibacterial segment is anticipated to generate significant returns by 2030 due to the growing prevalence of ailments such as hepatitis, HIV, TB, and influenza, among others. By Infection Type • Bacterial • Fungal • Viral • Parasitic • Others By Distribution Channels • Hospitals • Clinics • Others The hospitals segment is reckoned to grow considerably over the forecast duration ascribing to the rising number of hospitals across the globe.
Competitive hierarchy The prime players definining the competitive terrain of this market vertical are Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (US), bioMérieux SA (France), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Hologic, Inc. (US), QIAGEN N.V. (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics Holdings plc (US), Quidel Corporation (US), Meridian Bioscience (US), Genetic Signatures Ltd. (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Epitope Diagnostics (US), Chembio Diagnostic Systems (US), Seegene, Inc. (South Korea), Co-Diagnostics (US), ELITechGroup (France), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International (US), Vela Diagnostics (Singapore) and Uniogen Oy (Finland).
Get More Information About This Report: https://wemarketresearch.com/reports/infectious-disease-treatment-market/349/
Frequently Asked Questions
What is the growth rate projection for Global Infectious Disease Treatment Market over 2022-2030?
What are the expansion determinants for Global Infectious Disease Treatment Market?
What are the major segments present in Global Infectious Disease Treatment Market?
What are the primary regions covered in the Global Infectious Disease Treatment Market?
Which is the fastest growing region in the Global Infectious Disease Treatment Market?
About We Market Research:
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact Us:
We Market Research
Phone: +1(650)-666-4592
Email: sales@wemarketresearch.com
